← Open Payments lookup

ASSAL TAVAKOLI PARSA: Open Payments

NPI 1609348671 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$870 in 32 payments from 9 companies in 2025. Trend: 2023 $134 · 2024 $211 · 2025 $870

Food & beverage: $870
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.5$241
Otsuka America Pharmaceutical, Inc.9$230
ABBVIE INC.7$159
Takeda Pharmaceuticals U.S.A., Inc.4$72
Neos Therapeutics, LP3$52
Janssen Pharmaceuticals, Inc1$36
E.R. Squibb & Sons, L.L.C.1$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26
Supernus Pharmaceuticals, Inc.1$26

Products named: FANAPT, REXULTI, VRAYLAR, TRINTELLIX, SPRAVATO, Adzenys XR-ODT, COBENFY, CAPLYTA.

Industry payments across CA — which companies pay providers there.